Assignee
INST REGIONAL CANCER MONTPELLIER
FR·0 granted patents·3 pending applications·0 citations·filing 2017–2022
Top patents by PatentIndex Score
3 records- 0134US2022137030A1In vitro method for assessing the risk of prostate side effect after treatment by ionizing radiationINST REGIONAL CANCER MONTPELLIER·Filed 2020·Application pending·0 cites
- 0232US2024336679A1Methods for the treatment of cancerINST REGIONAL CANCER MONTPELLIER·Filed 2022·Application pending·0 cites
- 0323US2024021315A1In vitro method for predicting the risk of developing a breast late effect after radiotherapyINST REGIONAL CANCER MONTPELLIER·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INST REGIONAL CANCER MONTPELLIER files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →